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Abstract
Background: Studies addressing the effects of aerobic exercise and a prudent diet on lipid and lipoprotein
concentrations in adults have reached conflicting conclusions. The purpose of this study was to determine the
effects of aerobic exercise combined with a prudent diet on lipid and lipoprotein concentrations in adults.
Methods: Studies were located by searching nine electronic databases, cross-referencing, and expert review. Two
independent reviewers selected studies that met the following criteria: (1) randomized controlled trials, (2) aerobic
exercise combined with diet recommendations (saturated/trans fat intake less than 10% of total calories and
cholesterol less than 300 mg/day and/or fiber intake ≥25 g/day in women and ≥35 grams per day in men), (3)
intervention ≥4 weeks, (4) humans ≥18 years of age, (5) published studies, including dissertations and Master’s
theses, (6) studies published in any language, (7) studies published between January 1, 1955 and May 1, 2009, (8)
assessment of one or more of the following lipid and lipoprotein concentrations: total cholesterol (TC), high-
density lipoprotein cholesterol (HDL-C), ratio of TC to HDL-C, non-HDL-C, low-density lipoprotein cholesterol (LDL-
C) and triglycerides (TG). Two reviewers independently extracted all data. Random-effects models that account for
heterogeneity and 95% confidence intervals were used to pool findings.
Results: Of the 1,401 citations reviewed, six studies representing 16 groups (8 intervention, 8 control) and up to
559 men and women (282 intervention, 277 control) met the criteria for analysis. Statistically significant
intervention minus control reductions were found for TC (-15.5 mg/dl, 95% CI, -20.3 to -10.7), TC:HDL-C (-0.4 mg/dl,
95% CI, -0.7 to -0.2), LDL-C (-9.2 mg/dl, 95% CI, -12.7 to -5.8) and TG (-10.6 mg/dl, 95% CI, -17.2 to -4.0) but not
HDL-C (-0.5 mg/dl, 95% CI, -4.0 to 3.1). Changes were equivalent to reductions of 7.5%, 6.6%, 7.2% and 18.2%
respectively, for TC, TC:HDL-C, LDL-C and TG. Because of missing variance statistics, non-HDL-C was excluded.
Conclusions: Aerobic exercise combined with a prudent diet is highly efficacious for improving TC, TC:HDL-C, LDL-
C and TG, but not HDL-C concentrations, in adults. However, additional studies are needed, including effectiveness
studies using intention-to-treat analysis.
Background
Cardiovascular disease (CVD) is a major public health
problem with more than 81 million American adults
(about one in three) having one or more types of CVD
[1]. In terms of mortality, the estimated annual death
rate from CVD in the United States was 831,272,
approximately 34.3% of all deaths, in 2006 [1]. The costs
associated with CVD are also high. In 2010, the annual
total direct and indirect costs associated with CVD in
the United States were estimated to be $503.2 billion
[1]. One of the major risk factors for CVD is less than
optimal lipid and lipoprotein concentrations, a common
problem among American adults. In 2006, the preva-
lence of less than optimal concentrations of lipids and
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cholesterol (TC), 35.1 million for high-density lipopro-
tein cholesterol (HDL-C) and 71.2 million for low-den-
sity lipoproteins cholesterol (LDL-C) [1], the primary
target of lipid lowering therapy in adults [2]. These pre-
valence rates included 46.8% of all American adults for
TC, 16.2% for HDL-C and 32.6% for LDL-C [1].
Physical activity and a prudent diet, defined as a diet
in which saturated/trans fat intake is less than approxi-
mately 10% of total calories and cholesterol is less than
300 mg/day and/or fiber intake is ≥25 g/day in women
and ≥35 g/day in men, are low cost lifestyle changes
that have been recommended for improving lipid and
lipoprotein concentrations, especially LDL-C, in adults
[3]. However, randomized controlled trials that have
employed diets aimed at improving lipids and lipopro-
teins but may or may not meet the previously stated
definition, have led to conflicting findings [4-19]. Meta-
analysis is an approach that can increase statistical
power for primary endpoints and subgroups, resolve
uncertainty when studies disagree, improve estimates of
treatment effect and answer questions not posed at the
start of individual trials [20]. Given the conflicting find-
ings and strengths of meta-analysis, the purpose of this
study was to use the aggregate data meta-analytic
approach to determine the effects of recommendations
to perform aerobic exercise combined with recommen-
dations to consume a prudent diet on lipid and lipopro-
tein concentrations in adults.
Methods
Data sources
For this proposed project, studies were located by
searching nine electronic databases (PubMed, EMBASE,
CINAHL, Cochrane Central Register of Controlled
Trials, SportDiscus, Dissertation Abstracts International,
Physiotherapy Evidence Database (PEDRO), Latin Amer-
ican and Caribbean Health Sciences Database (LILACS),
Web of Science), cross-referencing from retrieved stu-
dies, and expert review (SR, WH). Major key words
used in the electronic database searches included, but
were not limited to, exercise, diet, and cholesterol. Per
the recent Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) recommenda-
tions [21], the search criteria for one of the databases
searched (PubMed) is shown in Additional File 1.
Study selection
Studies were included if they met the following criteria:
(1) randomized controlled trials, (2) aerobic exercise
combined with diet recommendations in which satu-
rated/trans fat intake was less than approximately 10%
of total calories and cholesterol was less than 300 mg/
day and/or fiber intake was ≥25 g/day in women and
≥35 g/d in men, (3) intervention ≥4 weeks, (4) humans
≥18 years of age, (5) published studies, including disser-
tations and Master’s theses, (6) studies published in any
language, (7) studies published between January 1, 1955
and May 1, 2009, (8) assessment of one or more of the
following concentrations of lipids and lipoproteins: TC,
H D L - C ,r a t i oo fT Ct oH D L - C ,n o n - H D L - C ,L D L - C ,
TG. The year 1955 was chosen as the starting point for
potential inclusion of studies since this appeared to be
the first time that an intervention on this topic had
been conducted [22]. Exclusion criteria included any
studies not meeting the criteria above. All studies were
selected by the first two authors with discrepancies
r e s o l v e db yc o n s e n s u sa sw e l la sc o n s u l t a t i o nw i t ht h e
last two authors if consensus could not be reached.
Data abstraction
Prior to coding all studies, an electronic codebook was
developed. The major categories that were coded
included (1) study characteristics, (2) subject characteris-
tics, (3) diet and exercise program characteristics and (4)
changes in primary and secondary outcomes. All studies
were coded by the first two authors, independent of
each other. They then reviewed every item for accuracy
and consistency. Disagreements were resolved by con-
sensus. When consensus could not be reached, the
other two authors served as arbitrators. Using Cohen’s
kappa statistic [23], the overall agreement rate (yes/no)
prior to correcting discrepant items was 0.94.
The original study protocol included an examination
of study quality using a previously developed instrument
[24]. However, since the time that the original study
protocol was developed, the use of quality scales has
been discouraged by the Cochrane Collaboration
because of the lack of empirical evidence [25,26], includ-
ing validity [27], to support the use of such. Therefore,
the study protocol was revised in favor of the risk of
bias assessment tool recently recommended by the
Cochrane Collaboration [28]. This tool assesses bias
across six domains: (1) sequence generation, (2) alloca-
tion concealment, (3) blinding to group assignment, (4)
incomplete outcome data, (5) selective outcome report-
ing, and (6) other potential bias [28]. Each domain is
classified as having either a high, low, or unclear risk of
bias [28]. For this study, risk of bias was limited to the
primary outcomes (TC, HDL-C, ratio of TC to HDL-C,
non-HDL-C, LDL-C and TG). The decision rule for
blinding was that all studies were at a low risk for bias
given the methods that are used to assess lipid and lipo-
protein concentrations in adults. Risk of bias was also
assessed with respect to whether participants had been
participating in a regular program of physical activity
prior to enrollment. All assessments were conducted by
the first two authors, independent of each other. Both
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ment. Disagreements were resolved by consensus. Using
Cohen’s kappa statistic [23], overall inter-rater agree-
ment prior to correcting discrepant items was 0.72, con-
sidered to be substantial [29].
Statistical analysis
Calculation of treatment effects from each study
The primary outcomes included in this meta-analysis
were concentrations of TC, HDL-C, ratio of TC to
HDL-C, non-HDL-C, LDL-C and TG. Effect sizes for
lipid and lipoprotein variables for each group from each
study were calculated by subtracting the change score in
t h ei n t e r v e n t i o n( a e r o b i ce x e r c i s ea n dd i e t )g r o u pf r o m
the change score in the control group. Variances were
calculated from the pooled standard deviations of
change scores in the intervention and control groups. If
change score standard deviations were not available,
these were calculated from 95% confidence intervals or
pre and post standard deviation values according to pro-
cedures developed by Follmann et al [30]. Each effect
size was then weighted by the inverse of its variance.
The original metric (milligrams per deciliter) versus
some type of standardized metric was used based on the
belief that the former is more clinically meaningful [31].
Secondary outcomes (changes in body weight, body
mass index (BMI) in kg/m
2, waist-to-hip ratio (WHR),
maximum oxygen consumption (VO2max ml
.kg
-1.min
-1),
intake of total kilocalories, carbohydrates, total fat, satu-
rated fat, cholesterol) were calculated using the same
approach as those used for lipid and lipoprotein out-
comes. Insufficient data were available for pooling non-
HDL-C, percent body fat, lean body mass, waist circum-
ference, fiber and trans-fat.
Pooled estimates of treatment effects for primary and
secondary outcomes
Random-effects models that incorporate heterogeneity
into the model were used to pool all primary and sec-
ondary outcomes from each study [32]. Multiple groups
from the same study were treated independently as well
as after collapsing groups so that only one effect size
was available from each study. If the two-tailed 95%
confidence intervals generated from the models did not
cross zero, results were considered to be statistically
significant.
Heterogeneity was assessed using Cochran’s Q statistic
and an alpha value for statistical significance of 0.10
[33]. Inconsistency of effect sizes between studies was
examined using an extension of the Q statistic, I
2 [34].
Generally, I
2 values of 25% to <50%, 50% to <75%, and
≥75% are considered to represent small, medium, and
large amounts of inconsistency [34].
Potential publication bias was examined using the data
imputation approach of Duval and Tweedie [35] while
the influence of each study on the overall results was
examined by deleting each study from the model once.
Cumulative meta-analysis, ranked by year, was used to
examine results over time [36]. Prediction intervals
(95%) were calculated to determine treatment effects in
a new trial [37,38].
Simple, random effects meta-regression (method of
moments approach) was conducted to examine the asso-
ciation between changes in lipid and lipoprotein concen-
trations and age, gender, baseline lipid and lipoprotein
concentrations, length of the intervention in weeks and
changes in body weight [39]. For secondary outcomes,
simple meta-regression was also conducted in order to
examine the association between changes in dietary out-
comes (total kilocalories, carbohydrates, total fat, satu-
rated fat, cholesterol) and gender as well as whether
dietary recommendations included a reduction in total
intake of kilocalories. In addition, the association
between changes in body weight and gender was also
examined. Non-overlapping 95% confidence intervals for
the slope (b1) were considered statistically significant.
Descriptive statistics were generated using PASW, ver-
sion 18.0 [40], reliability statistics using Excel 2007 [41],
and all meta-analytic analyses using Comprehensive
Meta-Analysis, version 2.2 [39,42]. Data are reported as
mean ± standard deviation ( ¯ X ± SD), medians (Mdn),
percentages (%) and 95% confidence intervals (95% CI).
Results
Study characteristics
A general description of the characteristics of the stu-
dies is shown in Table 1. Of the 1,401 citations
reviewed, six studies representing 16 groups (8 interven-
tion, 8 control) and up to 559 men and women (282
intervention, 277 control) met the criteria for inclusion
[8,10,15,43-45]. A description of this process, including
reasons for excluded studies, is shown in Figure 1. A list
of excluded studies is available on request from the cor-
responding author. The number of intervention and
control groups exceeded the number of studies because
two studies reported data separately for men and
women [15,45]. Dropout rates from the 4 studies and 5
groups in which data were available ranged from 0 to
10.6% in the intervention groups ( ¯ X ± SD, 7.1 ± 4.2,
Mdn, 9) and 0 to 9.0% in the controls ( ¯ X ± SD,4 . 2±
4.5, Mdn, 3) [8,43-45]. One study reported that one sub-
ject dropped out of the intervention group because they
were dissatisfied with group assignment while another
dropped out because of time constraints [8]. Another
study reported that one subject in the control group
was dropped because they failed to attend a follow-up
exam [43]. The final number of participants ranged
from 22 to 48 in the intervention groups ( ¯ X ± SD,3 8±
9, Mdn, 41) and 22 to 46 in the control groups
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trolled trials received some type of external funding and
were published in English-language journals between
1991 and 2002 [8,10,15,43-45]. Four studies were con-
ducted in the United States [8,10,15,45] and one each in
Sweden [43] and New Zealand [44]. All of the studies
appeared to use the per-protocol approach (efficacy ana-
lysis) in the treatment of their data [8,10,15,43-45]. One
study reported using the Efron procedure to balance
sample size, HDL-C and LDL-C levels [15] while two
others stratified participants by either race (African-
American versus other) [8] or gender [45]. None of the
studies used a crossover design [8,10,15,43-45].
Results for risk of bias are shown in Figure 2 and
Additional File 2. Based on our assessment procedures,
all of the studies were considered to be at a low risk of
bias with respect to sequence generation and blinding
[8,10,15,43-45]. The procedures for allocation conceal-
ment were determined to be unclear in four studies
[10,15,43-45] and low in one [8]. Assessment for bias in
relation to incomplete data was classified as unclear in
four studies [10,15,44,45] and low in two others [8,43].
Since none of the studies provided a protocol number
[8,10,15,43-45], the presence of outcome reporting bias
was categorized as unclear for all of them. Potential risk
of bias in relation to participation in exercise prior to
Table 1 Characteristics of Included Studies
Study &
Year
Country Participants
a Exercise Diet Lipid Assessment
Hellenius
et al.
(1993)[43]
Sweden 78 men, 35-60 yrs of age,
assigned to an exercise and
diet (n = 39) or control (n = 39)
group
24-wks of unsupervised
and supervised aerobic
activity, 2-3x wk, 30-45
min/d, 60%-80% MHR
NCEP Step 1 diet (fat <30% of
total kcals, saturated fat <10%,
polyunsaturated fat ≤ 10%,
monounsaturated fat 10%-15%,
carbohydrates 50%-60%, protein
10%-20%, cholesterol <300 mg/
d
TC, HDL-C, LDL-C, TG after an
overnight fast and avoiding
exercise for at least 24-hr
McAuley
et al.
(2002)[44]
New
Zealand
52 men and women, 30-68
years of age assigned to an
exercise and diet (n = 29) or
control (n = 23) group
16-wks supervised &
unsupervised aerobic
exercise, 5x wk, 30 min/d
<32% of total kcals from fat, ≤
11% of total kcals from
saturated fat, 14% from
monounsaturated fat, 7% from
polyunsaturated fat, 50% from
carbohydrates, 18% from
protein, < 200 mg cholesterol
and > 25 g fiber per/d
Fasting TC, HDL-C, LDL-C, TG
Miller et
al. (2002)
[8]
USA 43 hypertensive, overweight
adults, 22 to 70 yrs of age,
assigned to either an exercise
and diet (n = 20) or control (n
= 23) group
9-wks of supervised
aerobic exercise (walking
or cycle ergometry), 3x
wk, 30-45 min/d, 50%-75%
MHR
Hypocaloric version (2100 kcals)
of DASH diet (18% kcals from
protein, 55% from carbohydrate,
6% saturated fat, 13%
monounsaturated fat, 8%
polyunsaturated fat, 500 mg/d
magnesium, 1240 mg/d
calcium, 4700 mg/d potassium,
31 g/d fiber, 150 mg/d
cholesterol, 100 mmol/d
sodium
TC, HDL-C, LDL-C, TG after
fasting
Nieman
et al.
(2002)[10]
USA 44 sedentary obese women, 25-
75 yrs of age, assigned to either
an exercise and diet (n = 22) or
attention control stretching (n
= 22) group
12-wks walking, 5x wk (4
supervised, 1
unsupervised), 45 min/d,
60% to 80% MHR
1200-1300 kcals, NCEP Step 1
diet (55% carbohydrate, 30%
total fat, ≤ 10% saturated fat,
<300 mg/d of cholesterol)
TC, HDL-C, TC/HDL-C, LDL-C,
TG
Stefanick
et al.
(1998)[15]
USA 182 men and women, 30 to 64
yrs of age with low levels of
HDL-C and high levels of LDL-
C, assigned to either an
exercise and diet (n = 91) or
control (n = 91) group
52-wks supervised and
unsupervised brisk
walking and/or jogging,
60 min/d, 3x wk; goal was
10 miles brisk walking wk
NCEP Step 2 diet (< 30% total
fat, <7% saturated fat, < 200
mg cholesterol/d)
TC, HDL-C, TC/HDL-C, LDL-C,
TG in the morning after a 12
to 16-hr overnight fast and
avoiding vigorous physical
activity for at least 12 hr
Wood et
al. (1991)
[45]
USA 160 sedentary, overweight men
and women 25 to 49 yrs of age
assigned to either an exercise
and diet (n = 81) or control (n
= 79) group
52-wks supervised brisk
walking and jogging, 25-
45 min/d, 3x wk, 60% to
80% MHR
NCEP Step 1 diet (55%
carbohydrate, 30% total fat, ≤
10% saturated fat, <300 mg/d
of cholesterol)
TC, HDL-C, LDL-C, TG in the
morning after a 12 to 16-hr
overnight fast and avoiding
vigorous physical activity for
at least 12 hr
NOTES: Description of groups and all other variables limited to those that met our criteria for inclusion;
a Number of participants limited to those in which
changes in lipid and lipoprotein data were available; USA, United States of America; yrs, years; wk, week; wks, weeks; min, minutes; kcals, kilocalories; TC, total
cholesterol, HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; TC:HDL-C, ratio of total cholesterol to high-
density lipoprotein cholesterol; hr, hour; MHR, maximum heart rate; min/d, minutes per day; NCEP, National Cholesterol Education Program; mg/d, milligrams per
day; DASH, Dietary Approaches to Stop Hypertension.
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[43], low in three [10,44,45], and unclear in the remain-
ing two [8,15].
A description of the characteristics of the participants
is shown in Table 1 and Table 2. With respect to gen-
der, four studies included both men and women
[8,15,44,45], with two studies reporting data separately
for each [15,45]. Two other studies were restricted to
either men [43] or women [10]. The number of men
and women could not be calculated because data were
not available for all studies. For the two studies that
reported data on race/ethnicity, one reported that all
Initial records identified 
(n=2196)  
- PubMed (n=304)    - Web of Science (n=29)
- Embase (n=92)    - PEDro (n=196)
- LILACS (n=37)    - Sport Discus (n=404)
- CINAHL (n=303)    - DAI (n=338)
- Cochrane (n=493)
Records after duplicates removed
(n = 1401) 
Initial records screened based on title and 
abstract 
(n = 1401)
Records excluded (n = 1102),
with reasons*
- Abstract (n=7) 
- Animal study (n=91)
- Drug Intervention study (n=86)
- Lipids data not collected (n=1)
- Same participants as another 
study (15)
- Study limited to children and/or 
adolescents (n=101)
- Not a RCT (n=415) 
- Behavioral intervention (n=61)
- Control received intervention 
other than attention control or 
usual care (n=139)
- Not a diet & aerobic exercise 
study (n=227) 
Full-text articles 
assessed for eligibility 
(n = 299) 
Records excluded (n = 293),
with reasons*
- Abstract (n=2) 
- Animal study (n=1)
- Drug Intervention study (n=13) 
- Lipids data not collected (n=4) 
- Same participants as another 
study (19) 
- Not a RCT (n=140) 
- Behavioral intervention (n=82)
- Control received intervention 
other than attention control or 
usual care (n=61)
- Not a diet & aerobic exercise 
study (n=33) 
- Did not meet diet criteria (n=16)
Articles included in meta-analysis 
(n = 6)  
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Figure 1 Flow diagram for selection of articles. *, number of reasons exceeds the number of articles because some articles were excluded for
more than one reason.
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Page 5 of 15participants were Caucasian [44] while another reported
that 68% of the participants in the intervention group
and 57% of participants in the control group were Black
[8]. In relation to medication use of participants during
the trial, two studies reported that some participants
were taking some type of lipid medication prior to and
during the study [8,44] while another study representing
two groups reported that participants were not taking
any medications known to affect blood pressure or lipid
metabolism [45]. One study reported that none of the
women were taking any type of hormone replacement
therapy [45] while another reported that some were
[15]. For cigarette smoking, two studies consisting of
three groups reported that none of the participants
smoked [10,45] while two others reported that some did
[8,43]. Three studies reported that some of the partici-
pants consumed alcohol [8,43,44]. Participants were
reported as being sedentary in three studies comprising
Figure 2 Risk of bias assessment.
Table 2 Baseline characteristics of participants
Exercise Control
Variable # ¯ X ± SD Range Mdn # ¯ X ± SD Range Mdn
Age (years) 8 47.1 ± 5.9 39-57 47.0 8 46.9 ± 6.1 39-57 45.9
Body weight (kg) 7 86.3 ± 10.6 70-98 89.9 7 88.2 ± 12.5 70-103 90.5
BMI (kg
.m
2) 4 31.4 ± 3.5 26-34 32.7 4 32.1 ± 5.3 25-37 33.7
WHR 4 0.91 ± 0.07 0.8-1.0 0.93 4 0.91 ± 0.07 0.8-1.0 0.93
VO2max (ml
.kg
-1.min
-1) 5 31.3 ± 4.9 26-38 32.0 5 30.7 ± 4.9 26-38 29.0
Kilocalories (total) 6 2153 ± 305 1814-2616 2064 6 2153 ± 325 1814-2616 2090
Carbohydrates (%) 6 51 ± 5.2 44-57 52.5 6 51 ± 4.7 46-57 50.8
Total fat (%) 7 33.6 ± 3.6 28-38 33 7 33.9 ± 3.5 28-38 34.0
Saturated fat (%) 7 12.0 ± 2.1 9-14 12.4 7 12.0 ± 2.2 9-14 12.5
Cholesterol (mg) 5 282 ± 81 175-400 286 5 270 ± 85 175-400 256
TC (mg/dl) 8 218.6 ± 20.7 193-253 216.7 8 213.5 ± 16.7 193-239 209.0
HDL-C (mg/dl) 8 46.8 ± 7.6 36-58 45.5 8 45.7 ± 7.5 36-58 44.8
TC:HDL-C (mg/dl) 5 5.0 ± 1.0 3.6-6.4 4.9 5 5.2 ± 0.8 4.1-6.4 5.2
LDL-C (mg/dl) 8 145.2 ± 21.0 119-180 145.6 8 142.0 ± 15.9 119-161 141.7
TG (mg/dl) 7 86.8 ± 54.6 33-171 60.7 7 85.0 ± 55.6 33-171 60.7
Notes: #, number of groups in which data were available; With the exception of age, data limited to those in which change outcome results could be calculated;
Mdn, median; BMI, body mass index; WHR, waist to hip ratio; VO2max, maximum oxygen consumption; mg, milligrams; TC, total cholesterol; HDL-C, high-density
lipoprotein cholesterol; TC:HDL-C, ratio of TC to HDL; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; To convert TC, HDL-C and LDL-C from mg/dl to
mmol, divide by 38.46; To convert TG from mg/dl to mmol, divide by 87.72; Insufficient data reported for protein, polyunsaturated fat, saturated fat, and trans-fat
intake as well as non-HDL-C.
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Page 6 of 15four groups [10,44,45] while another study reported that
some participants were physically active prior to enroll-
ment [43]. One study reported no change in physical
activity among control group participants during the
intervention [43]. None of the studies reported whether
the physical activity habits of the participants in the
intervention groups changed outside of the intervention
itself. For the five studies that included women
[8,10,15,44,45], one each consisted of either premeno-
pausal [45] or postmenopausal [15] women while three
others included both [8,10,44]. Four studies representing
five groups reported that all participants were over-
weight or obese [8,10,44,45] while two others represent-
ing three groups reported that some participants were
overweight or obese [15,43]. With respect to hyperlipi-
demia, one study consisting of two groups reported that
all participants were hyperlipidemic [15] while four
others comprising five groups included some partici-
pants who were hyperlipidemic [8,10,43,45]. Five studies
representing six groups appeared to consist of partici-
pants without type 1 or type 2 diabetes [8,10,15,43,44].
One study reported that all participants were hyperten-
sive at study enrollment [8].
A description of the aerobic exercise component of the
intervention for each study is shown in Table 1. The
length of the interventions ranged from 9 to 52 weeks
( ¯ X ± SD, 34 ± 20, Mdn, 38). For those studies in which
data were available, the between-group frequency of aero-
bic training ranged from 2 to 5 times per week ( ¯ X ± SD,3
± 1, Mdn, 3). Mean between-group duration of training
for the three studies and four groups in which data were
available [10,15,43] ranged from 45 to 60 minutes per ses-
sion (¯ X ± SD, 55 ± 7, Mdn, 58). Within-group intensity of
training for the five studies and six groups in which data
were available [8,10,43-45] ranged from 50% to 90% of
maximum heart rate (MHR). We were unable to calculate
between-group statistics for intensity of training because
of a lack of reported data. Mean between-group minutes
of aerobic exercise for the three studies and four groups in
which data could be calculated ranged from 139 to 225
minutes per week ( ¯ X ± SD, 181 ± 35, Mdn, 180)
[10,15,43]. As can be seen in Table 1, walking was the
most common form of aerobic exercise prescribed. Com-
pliance for the two studies that reported such was 86% for
one study [8] and 95% for the other [10]. Compliance
appeared to be assessed by the investigator in the first
study [8] and by a combination of investigator and self-
reported assessment in the other [10]. Four studies repre-
senting five groups had participants perform both super-
vised and unsupervised exercise [10,15,43,44] while two
studies consisting of three groups had participants per-
form supervised exercise only [8,45]. All supervised exer-
cise appeared to be facility-based while unsupervised
exercise appeared to be home-based.
A description of the diet component of the interven-
tion for each study is shown in Table 1. Five studies
involved the provision of dietary recommendations
[10,15,43-45] while one study provided food [8]. Three
studies representing four groups used the National Cho-
lesterol Education Program (NCEP) Step 1 diet
[10,43,45], one study comprised of two groups used the
NCEP Step 2 diet [15] while another used the Dietary
Approaches to Stop Hypertension (DASH) diet [8].
Intentional weight loss was a component of the diet
intervention for all participants in three studies com-
prised of four groups [8,10,45] and for only those parti-
cipants who were overweight or obese in two other
studies [43,44]. For these studies, kilocalories (kcals)
consumed per day was limited to 2,100 in one study [8]
and 1,200 to 1,300 in another [10]. Two other studies
reported that kcals consumed per day were individually-
based [43,44]. For the five studies that reported informa-
tion on the assessment of nutrition intake [10,15,43-45],
two studies representing three groups reported using
self-reported seven day food records [43,45] with one
reporting that food records were both self-reported and
interviewer administered [45]. One study each reported
the assessment of nutrition intake using either a three
day food record and 24 hour recall [10], four day diet
record [44], or four weekdays and one weekend day
from 24 hour dietary recall via telephone interviews
[10].
Results for the assessment of lipid and lipoprotein
concentrations are shown in Table 1. All but one study
[10] reported that participants fasted prior to lipid
assessment with fasting occurring for at least 12 hours.
Three studies also reported that exercise was avoided
for at least 12 hours prior to lipid assessment [15,43,45].
All reported that lipid and lipoprotein assessments
appeared to take place in the morning with one study
reporting duplicate measures [15]. Four studies reported
using the Friedwald formula for estimating LDL-C
[8,10,15,45]. Insufficient information was provided to
determine if lipid and lipoprotein concentrations were
assessed during the same season [8,10,15,43-45].
For those studies in which information was available,
assessment of body weight occurred using a standard
balance beam scale in three studies comprising five
groups [8,15,45] while another reported using a cali-
brated electronic scale [44]. Two studies representing
three groups reported that participants wore light cloth-
ing without shoes during body weight assessment [8,45].
One study consisting of two groups reported that body
weight was assessed during two visits [15]. Body mass
index was calculated from measurements of height and
weight. With respect to the assessment of waist to hip
ratio, two studies representing three groups reported
assessment with a tape measure at the narrowest part of
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Page 7 of 15the waist and the widest part of the hips [15,43]. Three
studies representing five groups reported the assessment
of VO2max in ml
.kg
-1.min
-1 using a treadmill [15,44,45].
Two studies consisting of four groups appeared to have
participants exercise to volitional fatigue [15,45] while
the third study estimated VO2max from a submaximal
treadmill test (Bruce protocol) [44].
Outcomes
Primary outcomes (changes in lipids and lipoproteins)
Changes in lipid and lipoprotein concentrations are
shown in Table 3 and Figures 3,4,5,6,7. As can be seen,
statistically significant intervention minus control reduc-
t i o n sw e r ef o u n df o rT C ,r a t i oo fT Ct oH D L - C ,L D L - C ,
and TG but not for HDL-C. Changes in non-HDL-C
could not be calculated because none of the studies
reported variance statistics for such. None of the studies
reported changes in non-HDL-C. Changes were equiva-
lent to intervention minus control reductions of 7.5%,
6.6%, 7.2% and 18.2%, respectively, for TC, ratio of TC to
HDL-C, LDL-C and TG. Significant heterogeneity and
inconsistency as well as overlapping prediction intervals
were found for all lipid and lipoprotein concentrations.
With each study deleted from the model once, results
remained statistically significant for TC, ratio of TC to
HDL-C, LDL-C, and TG while HDL-C remained non-sig-
nificant [see Additional Files 3,4,5,6,7]. When adjusted
for publication bias, results remained statistically signifi-
cant for TC (-14.7 mg/dl, 95% CI, -19.3, -10.1) and LDL-
C (-8.0 mg/dl, 95% CI, -11.3, -4.8). No adjustment for
publication bias was necessary for HDL-C, ratio of TC to
HDL-C, LDL-C or TG. Cumulative meta-analysis ranked
by year, showed that results have remained non-signifi-
cant for HDL-C and significant for TC, ratio of TC to
HDL-C, LDL-C and TG since at least 1998 [see Addi-
tional Files 8,9,10,11,12]. The direction of results did not
change when multiple groups from the same studies
were collapsed so there was only one effect size from
each study (TC,-16.5 mg/dl, 95% CI, -22.3, -10.8; HDL-C,
-1.2 mg/dl, 95% CI, -5.3, 2.8; ratio of TC to HDL-C, -0.4,
95% CI, -0.5, -0.3; LDL-C, -9.6 mg/dl, 95% CI, -13.2, -6.1;
TG, -8.4 mg/dl, 95% CI, -14.1, -2.8).
Meta-regression analyses resulted in several significant
associations. For TC, shorter interventions were asso-
ciated with greater reductions in TC (b1, 0.21, 95% CI,
0.03, 0.38) while greater increases in HDL-C were asso-
ciated with younger age (b1, -0.51, 95% CI, -0.90, -0.13),
longer interventions (b1, 0.16, 95% CI, 0.05, 0.26) and
greater decreases in body weight (b1, -1.44, 95% CI, -2.5,
-0.37). Greater decreases in the ratio of TC:HDL-C were
associated with being male (b1, -0.44, 95% CI, -0.82,
-0.06) and greater decreases in body weight (b1, 0.10,
95% CI, 0.03, 0.18). Greater decreases in TG were also
associated with larger decreases in body weight (b1,
3.20, 95% CI, 1.05, 5.35). No other significant associa-
tions were observed for any of our lipid and lipoprotein
concentrations.
Secondary outcomes
Results for secondary outcomes are shown in Table 3. A
statistically significant intervention minus control
Table 3 Changes in primary and secondary outcomes
Variable Studies (#) Participants (#) ES (#) ¯ X (95% CI) Q(p) I
2(%) 95% PI
Primary Outcomes
- TC (mg/dl) 6 559 8 -15.5 (-20.3, -10.7)
a 221.0 (<0.001)
a 96.8 -32.1, 1.1
- HDL-C (mg/dl) 6 559 8 -0.5 (-4.0, 3.1) 1678.9 (<0.001)
a 99.6 -13.6, 12.6
- TC:HDL-C 4 429 6 -0.4 (-0.7, -0.2)
a 11.5 (0.04)
a 56.7 -1.0, 0.1
- LDL-C (mg/dl) 6 559 8 -9.2 (-12.7, -5.8)
a 143.5 (<0.001)
a 95.1 -21, 2.5
- TG (mg/dl) 6 559 8 -10.6 (-17.2, -4.0)
a 691.9 (<0.001)
a 99.0 -32.5, 11.3
Secondary Outcomes
- Body weight (kg) 5 481 7 -5.7 (-7.4, -4.1)
a 26.7 (<0.001)
a 77.5 -11.0, -0.5
- BMI (kg/m
2) 4 217 4 -1.5 (-2.1, -0.8)
a 11.7 (0.008)
a 74.3 -4.2, 1.3
- WHR 3 312 4 -0.01(-0.015, 0.003) 4.0 (0.3) 25.8 -0.03, 0.02
-V O 2max(ml
.kg
-1.min
-1) 4 384 5 5.1 (2.7, 7.5)
a 33.2 (<0.001)
a 88.0 -3.9, 14.1
- Kilocalories (total) 4 450 6 -283 (-453, -114)
a 17.5 (0.004)
a 71.5 -805, 238
- Carbohydrates (%) 4 323 5 6.0 (4.0, 8.0)
a 18.6 (0.001)
a 78.4 -1.1, 13.2
- Total fat (%) 5 493 7 -7.6 (-9.8, -5.3)
a 54.1 (<0.001)
a 88.9 -15.3, 0.2
- Saturated fat (%) 4 348 5 -4.2 (-5.4, -3.1)
a 24.3 (<0.001)
a 83.6 -8.5, 0.1
- Cholesterol (mg) 3 386 5 -115 (-148, -83)
a 10.3 (<0.04)
a 61.2 -222, -9.0
Notes: ES, effect sizes; #, number in which data were available for; ¯ X (95% CI), mean and 95% confidence interval; Q(p), Cochran’s Q statistic for heterogeneity
and alpha value; I
2 (%), percent inconsistency statistic; 95% PI, 95% prediction intervals for a new study;
astatistically significant; TC, total cholesterol; HDL-C, high-
density lipoprotein cholesterol; TC:HDL-C, TC:HDL-C ratio; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; BMI, body mass index; WHR, waist to hip
ratio; VO2max, maximum oxygen consumption; %, percentage of total kilocalorie intake; To convert TC, HDL-C and LDL-C from mg/dl to mmol, divide by 38.46; To
convert TG from mg/dl to mmol, divide by 87.72.
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Page 8 of 15reduction was found for body weight and BMI but not
for WHR. Changes were equivalent to intervention
minus control reductions of 6.7%, 5.0% and 0.5%,
respectively for body weight, BMI and WHR. Statisti-
cally significant heterogeneity as well as inconsistency
was observed for body weight and BMI but not for
WHR. Overlapping prediction intervals were observed
for BMI and WHR but not for body weight. For VO2max
in ml
.kg
-1.min
-1, statistically significant intervention
minus control increases equivalent to 16.3% were found.
Statistically significant heterogeneity and/or inconsis-
tency as well as overlapping prediction intervals were
also identified. There was no significant association
between changes in body weight and gender (b1,- 1 . 6 ,
95% CI, -6.9, 3.6).
For daily nutrition intake, statistically significant inter-
vention minus control reductions were observed for
total kilocalories, percentage of kilocalories from total
fat, percentage of kilocalories from saturated fat, and
daily cholesterol consumption. In addition, there was a
statistically significant increase in the percentage of car-
bohydrates consumed. Across all studies, changes were
equivalent to intervention minus control improvements
of 14.9%, 12.0%, 23.1%, 34.7% and 42.1% respectively,
for total kilocalories, carbohydrates, total fat, saturated
fat and cholesterol. With the exception of prediction
intervals for cholesterol intake, statistically significant
heterogeneity and inconsistency as well as overlapping
prediction intervals were observed for all nutrition
outcomes.
Greater reductions in dietary outcomes were asso-
ciated with studies that recommended lower caloric
intake for total kilocalories (b1, -310, 95% CI, -475,
-146) and percentage of carbohydrates (b1, -3.0, 95% CI,
-5.7, -0.3) but not for percentage of total fat (b1, -0.4,
95% CI, -2.8, 2.0), percentage of saturated fat (b1,0 . 0 5 ,
95% CI, -0.9, 1.0) or cholesterol consumed (b1, -.45.9,
95% CI, -104.9, 12.5). In addition, there were no statisti-
cally significant associations between changes in dietary
outcomes and gender (total kilocalories, b1,1 7 9 . 1 ,9 5 %
CI, -149, 507; percentage of total fat, b1,0 . 9 ,9 5 %C I ,
-3.8, 5.6; percentage of saturated fat, b1, -0.7, 95% CI,
-1.7, 0.3; cholesterol b1, -41.0, 95% CI, -108.8, 26.9; per-
centage of carbohydrates b1, -.1.1 95% CI, -6.9, 4.7).
Study name Subgroup within studyStatistics for each study Difference in means and 95% CI
Difference Lower Upper 
in means limit limit
Hellenius et al., 1993 none -12.4 -14.6 -10.1
McAuley et al., 2002 none -15.5 -17.2 -13.8
Miller et al., 2002 none -25.0 -37.0 -13.0
Nieman et al., 2002 none -24.0 -25.5 -22.4
Stefanick et al., 1998 men -16.7 -25.1 -8.3
Stefanick et al., 1998 women -16.5 -25.0 -8.0
Wood et al., 1991 men -9.3 -11.4 -7.2
Wood et al., 1991 women -9.7 -11.0 -8.3
-15.5 -20.3 -10.7
-40.00 -20.00 0.00 20.00 40.00
Favors Treatment Favors Control
Figure 3 Forest plot for changes in TC.
Study name Subgroup within study Statistics for each study Difference in means and 95% CI
Difference Lower Upper 
in means limit limit
Hellenius et al., 1993 none -0.4 -0.9 0.2
McAuley et al., 2002 none -5.0 -5.5 -4.6
Miller et al., 2002 none -5.0 -8.0 -2.0
Nieman et al., 2002 none -2.3 -2.8 -1.9
Stefanick et al., 1998 men 0.6 -1.4 2.6
Stefanick et al., 1998 women -2.1 -4.7 0.5
Wood et al., 1991 men 7.3 6.9 7.8
Wood et al., 1991 women 2.7 2.1 3.3
-0.5 -4.0 3.1
-10.00 -5.00 0.00 5.00 10.00
Favors Control Favors Treatment
Figure 4 Forest plot for changes in HDL-C.
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The purpose of this study was to determine the com-
bined effects of aerobic exercise and a prudent diet on
lipid and lipoprotein concentrations in adults. The over-
all results suggest that the combined effects of both are
efficacious for reducing concentrations of TC, the ratio
of TC to HDL-C, LDL-C and TG, but not increasing
HDL-C, in adults. These findings appear to be impor-
tant from a practical perspective, especially in relation
to the prevention of coronary heart disease (CHD), a
disease with an annual estimated incidence rate in the
United States of more than 1.4 million people [1]. For
example, it has been reported that every 1% reduction
in population levels of TC results in an approximate 2%
reduction in the rate of CHD [46]. Based on the findings
of the current study, this would result in a 15% reduc-
tion in the rate of CHD as a result of aerobic exercise
and a prudent diet. The decreases observed in the ratio
of TC to HDL-C also appear to be important with
changes based on previous research equivalent to reduc-
tions of approximately 21% in CHD risk [47]. In addi-
tion, Wilson et al [48], estimated that every 1%
population decrease in LDL-C would decrease the 12-
year incidence of CHD by 1%. Congruent with the
changes observed for LDL-C in the current meta-analy-
sis, this would be equivalent to a reduction of approxi-
mately 7% in the 12-year incidence of CHD.
Improvements in LDL-C may be particularly important
given that LDL-C is currently the primary target of
lipid-lowering therapy in adults [2]. Furthermore, based
on previous work, the decreases in serum TG observed
in the current investigation would be equivalent to
decreases in the relative risk of CHD of 2% in men and
4% in women [49]. Finally, the observed results may be
an underestimate of the true effects of aerobic exercise
combined with a prudent diet on lipid and lipoprotein
concentrations in adults given that participants tend to
overestimate their adherence to exercise and diet recom-
mendations [50,51].
The changes observed in TC, LDL-C and TG in the
current investigation appear to be greater than those
achieved with aerobic exercise alone. For example, pre-
vious meta-analytic work addressing the effects of aero-
bic exercise on lipid and lipoprotein concentrations in
Study name Subgroup within study Statistics for each study Difference in means and 95% CI
Difference Lower Upper 
in means limit limit
Miller et al., 2002 none -0.23 -0.74 0.28
Nieman et al., 2002 none -0.39 -0.75 -0.03
Stefanick et al., 1998 men -0.50 -0.88 -0.12
Stefanick et al., 1998 women -0.20 -0.51 0.11
Wood et al., 1991 men -1.05 -1.47 -0.63
Wood et al., 1991 women -0.34 -0.55 -0.13
-0.43 -0.65 -0.22
-2.00 -1.00 0.00 1.00 2.00
Favors Treatment Favors Control
Figure 5 Forest plot for changes in TC:HDL-C.
Study name Subgroup within study Statistics for each study Difference in means and 95% CI
Difference Lower Upper 
in means limit limit
Hellenius et al., 1993 none -7.7 -9.8 -5.7
McAuley et al., 2002 none -3.9 -5.3 -2.4
Miller et al., 2002 none -18.0 -30.0 -6.0
Nieman et al., 2002 none -13.5 -14.8 -12.2
Stefanick et al., 1998 men -15.4 -23.2 -7.6
Stefanick et al., 1998 women -12.0 -20.2 -3.8
Wood et al., 1991 men -2.7 -4.6 -0.8
Wood et al., 1991 women -10.1 -11.2 -8.9
-9.2 -12.7 -5.8
-40.00 -20.00 0.00 20.00 40.00
Favors Treatment Favors Control
Figure 6 Forest plot for changes in LDL-C.
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Page 10 of 15women [52] and men [53] yielded significant reductions
in TC, LDL-C and TG that were less than half those
observed in the current investigation. The ratio of TC to
HDL-C was not assessed in either study [52,53]. In con-
trast, prior meta-analytic work that examined the effects
of Step 1 and 2 diets from the American Heart Associa-
tion reported improvements in lipid and lipoprotein
concentrations that were similar to or larger than the
current investigation with respect to TC, ratio of TC to
HDL-C and LDL-C [54]. However, changes in TG were
less in this prior work [54]. The results of the prior
meta-analysis should be viewed with caution as it
appears that traditional statistical approaches versus
those specific to the conduct of meta-analysis were used
[54]. Consequently, the reported changes in lipid and
lipoprotein concentrations may be exaggerated.
While statistically significant and practically important
improvements were observed for TC, the ratio of TC to
HDL-C, LDL-C and TG, no such differences were
observed for HDL-C. The lack of effect on HDL-C may
not be surprising given that aerobic exercise alone has
been shown to increase concentrations of HDL-C in
both women [52] and men [53] while low total and
saturated fat diets have been shown to significantly
decrease HDL-C [54]. Thus, ita p p e a r st h a tt h ep o s i t i v e
effects of aerobic exercise on HDL-C may not override
the lowering effect of diets generally low in total and
saturated fat but may help to mitigate these changes
given that the current meta-analysis found a non-signifi-
cant decrease in HDL-C of 1.3% while low-fat only diets
resulted in a statistically significant decrease of 7%.
Given that participants with low concentrations of
HDL-C may respond less to exercise than those with
high concentrations, it is important to note that results
remained consistent when each study was excluded
from the model once, including the one study that
enrolled participants with initially low concentrations of
HDL-C [15]. With the former in mind, other forms of
therapy, for example, fibrates or niacin [55], may be
necessary for raising HDL-C in adults who exercise
aerobically and consume a low-fat diet. However, as pre-
viously noted, the results of the low-fat diet meta-analy-
sis may have been exaggerated [54]. Based on this
observation, it appears that a need exists for an updated
meta-analysis of randomized controlled trials to deter-
mine the effects of low-fat only diets on lipid and lipo-
protein concentrations, especially HDL-C, in adults.
The changes observed in the current study for TC,
LDL-C and HDL-C are generally less than those reported
for statin therapy and equal to or greater than changes
reported for TG [56]. For example, previous meta-analy-
tic research on the effects of statins on lipid and lipopro-
tein concentrations reported improvements ranging from
17% to 31%, 7% to 12%, 26% to 46% and 10% to 18%
respectively, for TC, HDL-C, LDL-C and TG [56]. Gener-
ally speaking, our findings support current recommenda-
tions regarding the use of aerobic exercise and a prudent
diet as a first line strategy for maintaining optimal con-
centrations of lipids and lipoproteins in adults [2]. If opti-
mal levels cannot be attained, aerobic exercise and diet
should still be recommended with the possible addition
of fibrates or niacin [55] for increasing HDL-C and/or a
statin for improving all other lipid and lipoprotein con-
centrations, especially LDL-C [56].
Statistically significant reductions were found for body
weight and BMI while changes in the direction of bene-
fit were observed for WHR as a result of the aerobic
exercise and diet intervention. In addition, a statistically
significant increase in VO2max in ml.kg
-1.min
-1 was
observed. These findings are not surprising given that
weight loss and increases in cardiorespiratory fitness are
common changes that occur as a result of aerobic exer-
cise and a prudent diet. Given that significant reductions
were found for total kilocalories, total fat, saturated fat
and cholesterol, it appears, overall, that participants
were successful in adhering to the assigned diet.
Study name Subgroup within study Statistics for each study Difference in means and 95% CI
Difference Lower  Upper 
in means limit limit
Hellenius et al., 1993 none -7.0 -8.4 -5.5
McAuley et al., 2002 none -2.3 -3.4 -1.2
Miller et al., 2002 none 7.0 -10.0 24.0
Nieman et al., 2002 none -18.9 -20.3 -17.6
Stefanick et al., 1998 men -15.6 -44.1 12.9
Stefanick et al., 1998 women -12.4 -31.7 6.9
Wood et al., 1991 men -25.5 -27.5 -23.6
Wood et al., 1991 women -5.8 -6.7 -4.9
-10.6 -17.2 -4.0
-45.00 -22.50 0.00 22.50 45.00
Favors Treatment Favors Control
Figure 7 Forest plot for changes in TG.
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Page 11 of 15While the results of this study are encouraging, they
must be viewed with respect to several issues. First,
while simple meta-regression analyses yielded several
significant associations with selected concentrations of
lipids and lipoproteins, these should be viewed with cau-
tion given the small sample size. In addition, since stu-
dies are not randomly assigned to predictors, such
analyses are considered to be observational in nature
[57]. Consequently, such analyses do not support causal
inferences [57]. Rather, the validity of these findings
would need to be tested in large, well-designed rando-
mized controlled trials. This may be especially relevant
for determining whether changes in selected lipid and
lipoprotein concentrations are the result of the com-
bined effects of aerobic exer c i s ea n dap r u d e n td i e to r
the weight loss associated with a combination of aerobic
exercise and a prudent diet.
Second, with the exception of the WHR, statistically
significant heterogeneity and a large amount of inconsis-
tency was observed for all of our primary and secondary
outcomes. While random effects models account for
heterogeneity, resulting in narrower confidence intervals
when heterogeneity is present, others have suggested
that it is not appropriate to reach conclusions based on
aggregate findings when there is significant heterogene-
ity and/or inconsistency [28]. However, heterogeneity
(Q) and inconsistency (I
2) statistics do not guarantee
that the dispersion in results are large enough to be of
practical or theoretical importance [58]. In addition, no
significant differences were found for any of our out-
comes when each study was deleted from the model
once as well as when selected results were adjusted for
publication bias. Furthermore, based on our cumulative
meta-analyses, the direction of results for all of our out-
comes has remained stable for more than a decade.
A third issue has to do with the fact that overlapping
prediction intervals were observed for all outcomes
except changes in body weight and cholesterol intake.
From a practical perspective, prediction intervals may be
more relevant since they provide an approximation of
the expected treatment effect in a new trial [37,38].
However, they should not be used to determine whether
confidence intervals from a random effects model are
correct or incorrect since prediction intervals are based
on a random mean effect while confidence intervals are
not [37,38].
A fourth issue has to do with the lack of studies avail-
able after the investigative team’s strict inclusion criteria
were applied. This was especially surprising given the
fact that aerobic exercise and a diet low in total and
saturated fat are common first line strategies for treating
dyslipidemia [2,3]. In addition, it was surprising to see
that the most recent study that met our strict inclusion
criteria had been published in 2002 [8,10,44]. While this
may have been the result of possible search error, there
may also be a general belief that the beneficial effects of
this intervention are well established and that no further
research in this area is necessary. However, this may be
shortsighted. For example, all of the included studies
appeared to conduct ‘as treated’ analyses in determining
the combined effects of aero b i ce x e r c i s ea n dap r u d e n t
diet on lipid and lipoprotein concentrations in adults.
While such an approach can determine the efficacy of
findings, it cannot determine the effectiveness of find-
ings [59]. Therefore, it would appear plausible to suggest
that future studies are needed that include both efficacy
(as-treated) and effectiveness (intention-to-treat) ana-
lyses and that such studies focus on the Therapeutic
Lifestyle Changes currently recommended by the
National Cholesterol Education Program and American
Heart Association [2,3]. Such knowledge would address
the issue of whether the currently recommended treat-
ment works (efficacy) as well as whether it works in the
real world (effectiveness) [59]. Knowledge of both is
especially important with respect to the allocation of
resources for treating dyslipidemia.
A fifth issue has to do with the general lack of report-
ing for certain information in the included studies. For
example, it was difficult to assess the risk of bias with
respect to allocation concealment, incomplete data and
outcome reporting. It is suggested that future studies
report this information, including a study protocol iden-
tification number. Future studies should also ensure that
all participants were not exercising on a regular basis
prior to enrollment and include a definition of such. In
addition, future research on this topic should include
data on the race/ethnicity of subjects, number of men
and women who started and completed the study, medi-
cation status of participants, including hormone replace-
ment therapy, cigarette smoking, alcohol intake,
percentage of body fat as an outcome variable, average
intensity of training for aerobic exercise, compliance to
the aerobic exercise protocol, whether the exercise
habits of participants changed outside of the interven-
tion, protein, fiber, and trans-fat intake as well as the
season(s) in which lipids and lipoproteins were assessed
and the number of hours that exercise was avoided
prior to assessment. Finally, since non-HDL-C has been
shown to be a better predictor of cardiovascular mor-
bidity and mortality than LDL-C [60,61], currently, the
primary target of lipid lowering therapy in adults [2],
the inclusion of data for non-HDL-C, including disper-
sion statistics, is also recommended in future studies.
A sixth issue has to do with the use of traditional
meta-analytic models that were employed in the current
meta-analysis. While more recent meta-analytic methods
have been proposed [62-68], it was the investigative
team’s position that (1) it would be imprudent to
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of the newer alternatives proposed as a means of dealing
with specific problems in meta-analysis may have pro-
blems of their own, possibly with substantially worse
impact than the problems they were intended to solve
(Dr. Michael Borenstein and Dr. Larry Hedges, personal
communication, 22 February and 25 February 2011).
Finally, the focus of the current meta-analysis was on
the combined effects of aero b i ce x e r c i s ea n dap r u d e n t
diet on lipid and lipoprotein concentrations in adults.
However, there may also be an interest in future meta-
analytic work aimed at determining the independent
effects of aerobic exercise, dietary fat reduction and
weight loss on lipid and lipoprotein concentrations in
adults. Ideally, this would best be accomplished by limit-
ing the inclusion of studies to randomized controlled
trials in which all of these intervention arms are
included within the same study.
In conclusion, aerobic exercise and a prudent diet are
efficacious for improving TC, TC:HDL-C, LDL-C and
TG, but not HDL-C concentrations, in adults. However,
a need exists for additional studies on this topic, includ-
ing effectiveness studies using intention-to-treat analysis.
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additional figure contains the results for changes in the ratio of TC:HDL-C
with each study deleted from the model once.
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